XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Investments    
Debt instruments, trading, at fair value $ 1,737 $ 22,473
Equity securities, trading, at fair value 1,195,864 844,001
Other investments, at fair value 139,165 156,063
Total investments 1,336,766 1,022,537
Cash and cash equivalents 31,887 39,858
Restricted cash and cash equivalents 1,349,989 1,202,651
Financial contracts receivable, at fair value 20,644 76,381
Reinsurance balances receivable 294,253 219,126
Loss and loss adjustment expenses recoverable 18,447 2,704
Deferred acquisition costs, net 77,241 61,022
Unearned premiums ceded 6,131 2,377
Notes receivable, net 29,653 33,734
Other assets 5,697 4,303
Total assets 3,170,708 2,664,693
Liabilities    
Securities sold, not yet purchased, at fair value 890,001 859,902
Financial contracts payable, at fair value 10,409 2,237
Due to prime brokers 547,699 319,830
Loss and loss adjustment expense reserves 445,778 306,641
Unearned premium reserves 281,618 222,527
Reinsurance balances payable 76,292 41,415
Funds withheld 16,487 5,927
Other liabilities 12,739 14,527
Performance compensation payable to related party 3,955 0
Total liabilities 2,284,978 1,773,006
Equity    
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued) 0 0
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 31,093,858 (2016: 31,111,432): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,895 (2016: 6,254,895)) 3,735 3,737
Additional paid-in capital 501,766 500,337
Retained earnings 362,004 370,168
Shareholders’ equity attributable to shareholders 867,505 874,242
Non-controlling interest in joint venture 18,225 17,445
Total equity 885,730 891,687
Total liabilities and equity $ 3,170,708 $ 2,664,693